Can you be infected by COVID-19 twice?

James Marshall
November 22, 2020

Now, a release from the American Society for Microbiology reveals the amount of Immunoglobulin G (IgG) mumps antibodies in the body directly ties to how sick a COVID-19 patient gets.

Researchers from the University of Central Florida used 3D modeling and computer simulations to experiment how far sneeze droplets travel in people with different physiological features, such as nasal flow and teeth structure.

The study has raised hopes that the protection conferred by coronavirus vaccines could last for years, and that an annual jab may not be required.

Questions over how long COVID-19 immunity lasts have been asked since the virus began escalating across the world in early 2020.

They indicated that having the virus once "provides at least short-term protection" from getting it again, she said.

"High demand combined with a limited supply will make COVID-19 vaccines the equivalent of liquid gold to organized crime networks as soon as one is available."Jurgen Stock, Interpol Secretary-General said". This includes cells that produce targeted antibodies that can stick to the virus in order to stop it - and T cells that can attack just the cells infected with the virus, called the cellular response.

It is also good news for immunisation programmes, because if the body can provoke a long-term immune response naturally, it should also do so when triggered by a vaccine.

The virus could thus be "terminated fast enough that not only are you not experiencing any symptoms, but you are not infectious", added Dr Alessandro Sette, an immunologist and co-author of the study.

For the research, blood samples from 185 patients between the ages of 19 to 81 who had tested positive for the coronavirus were collected.

Coronavirus immunity in some people may last more than six months, early research suggests
Children have low Covid-19 rates because they are protected by the MMR jab, study claims - SamfordCrimson News

But none of the three became unwell. Participants older than 80, frail patients, and those with substantial chronic illnesses were excluded, according to an editorial published with the study.

"Our results indicate that antiviral antibodies against SARS-CoV-2 did not decline within 4 months of diagnosis", wrote the authors.

The current MMR vaccine was developed by Maurice Hilleman and was licensed for use by Merck in 1971.

The staff tested were followed for up to 30 weeks.

Scientists are developing understanding of the role of T-cells but a recent study found people testing negative for coronavirus antibodies may still have some immunity.

Staff with antibodies were also less likely to test positive for COVID-19 without symptoms.

Coronavirus is absolutely a new infection in people and people don't have immunity to the virus when the pandemic started.

One of these studies, for instance, found that antibody levels "waned quite rapidly" after infection in the British population, suggesting a risk of multiple infections, Health24 reported. Most of the adults had mild disease.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER